Allen S. Melemed

Gemcitabine Plus Paclitaxel Versus Paclitaxel Monotherapy in Patients With Metastatic Breast Cancer and Prior Anthracycline Treatment

Kathy S. Albain, Shona Nag, G. Calderillo-Ruiz et al. · Journal of Clinical Oncology · 2008 · 422 citations · Full text

Medicine, Oncology, Pharmacology +17

Gemcitabine as First-Line Therapy in Patients with Metastatic Breast Cancer: A Phase II Trial

Martin E. Blackstein, C. L. Vogel, Roy M. Ambinder et al. · Oncology · 2002 · 161 citations

Medicine, Oncology, Pharmacotherapy +17

Global phase III study of gemcitabine plus paclitaxel (GT) vs. paclitaxel (T) as frontline therapy for metastatic breast cancer (MBC): First report of overall surviva

Kathy S. Albain, S. Nag, G. Calderillo-Ruiz et al. · Journal of Clinical Oncology · 2004 · 155 citations

Medicine, Oncology, Pharmacology +12

ONC201 (Dordaviprone) in Recurrent H3 K27M–Mutant Diffuse Midline Glioma

Isabel Arrillaga‐Romany, Sharon L. Gardner, Yazmín Odia et al. · Journal of Clinical Oncology · 2024 · 96 citations · Full text

Medicine, Oncology, Pharmacology +11

A phase II trial of arzoxifene, a selective estrogen response modulator, in patients with recurrent or advanced endometrial cancer

D. Scott McMeekin, Alan N. Gordon, Jeffrey M. Fowler et al. · Gynecologic Oncology · 2003 · 82 citations

Medicine, Oncology, Pharmacology +12